Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PFE

Pfizer Inc

Feb 17 • 04:00PM ET

27.37

-0.21 -0.76 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Feb 17, 6:50 AMPfizer announces positive topline Phase 3 BREAKWATER Cohort 3 results showing its BRAFTOVI (encorafenib) plus cetuximab and FOLFIRI regimen significantly improves progression-free survival in previously untreated BRAF V600E-mutant metastatic colorectal cancer and will share the data with the FDA to support potential approval.

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	20.20	EPS (ttm)	1.36	Insider Own	0.12%	Shs Outstand	5.69B	Perf Week	1.18%
Market Cap	155.62B	Forward P/E	9.69	EPS next Y	2.82	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	5.72%
Enterprise Value	202.64B	PEG	-	EPS next Q	0.73	Inst Own	67.15%	Short Float	2.52%	Perf Quarter	6.13%
Income	7.75B	P/S	2.49	EPS this Y	-8.03%	Inst Trans	0.81%	Short Ratio	2.86	Perf Half Y	8.87%
Sales	62.58B	P/B	1.68	EPS next Y	-4.62%	ROA	4.58%	Short Interest	143.04M	Perf YTD	9.92%
Book/sh	16.32	P/C	10.39	EPS next 5Y	-8.81%	ROE	10.59%	52W High	27.94 -2.04%	Perf Year	7.21%
Cash/sh	2.64	P/FCF	15.00	EPS past 3/5Y	-37.12% -3.51%	ROIC	5.16%	52W Low	20.92 30.86%	Perf 3Y	-36.66%
Dividend Est.	1.75 (6.40%)	EV/EBITDA	7.75	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	76.10%	Volatility	2.06% 2.23%	Perf 5Y	-21.55%
Dividend TTM	1.72 (6.28%)	EV/Sales	3.24	EPS Y/Y TTM	-3.74%	Oper. Margin	27.83%	ATR (14)	0.63	Perf 10Y	-2.53%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	-1.65%	Profit Margin	12.38%	RSI (14)	59.77	Recom	2.43
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.28	EPS Q/Q	-509.90%	SMA20	2.96%	Beta	0.43	Target Price	28.66
Payout	126.47%	Debt/Eq	0.66	Sales Q/Q	-1.16%	SMA50	5.79%	Rel Volume	0.62	Prev Close	27.58
Employees	81000	LT Debt/Eq	0.62	Earnings	Feb 03 BMO	SMA200	10.12%	Avg Volume	50.06M	Price	27.37
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.42% 4.20%	Trades		Volume	32,119,860	Change	-0.76%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43

Show Previous Ratings

Feb-17-26 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
10:30AM	CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock? (Zacks)
10:15AM	Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial (Benzinga)
06:45AM	Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer (Business Wire)
Feb-14-26 02:04PM	Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25 (MarketBeat)
01:28AM	Loading…
01:28AM	Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings (Insider Monkey)
Feb-13-26 08:57PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
04:57PM	Analyst Report: Zoetis Inc. (Morningstar Research)
09:57AM	Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? (Insider Monkey)
Feb-12-26 12:00PM	Kahn Brothers Reduces Stake in Pfizer Inc by 21.66% (GuruFocus.com)
10:38AM	MDGL Strengthens MASH Franchise With New Genetic Approaches (Zacks)
08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More (24/7 Wall St.)
Feb-11-26 01:30PM	Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish (Barchart)
12:57PM	Pharma companies left out of Trump's drug-pricing deals look for way in (Reuters)
10:35AM	Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders (Insider Monkey)
08:09AM	Loading…
08:09AM	Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? (Zacks)
08:01AM	CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside (Zacks)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
11:06AM	Will BMY's Legacy Portfolio Decline Weigh on Its 2026 Top Line? (Zacks)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
06:41AM	Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI (marstacimab) sBLA (Insider Monkey)
12:37AM	5 Revealing Analyst Questions From Pfizer's Q4 Earnings Call (StockStory)
Feb-09-26 10:29AM	BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
09:11AM	Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4? (Zacks)
Feb-07-26 08:00AM	Pfizer CEO discusses the company's GLP-1 weight-loss drug pipeline (Yahoo Finance Video)
Feb-06-26 05:13PM	TrumpRx Is Here. Most People Won't Benefit. (Barrons.com)
03:37PM	3 High-Yield Dividend Stocks Perfect For Retirees (24/7 Wall St.)
11:58AM	TrumpRx launches to slash drug prices for cash-paying US patients (Pharmaceutical Technology)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
08:00AM	China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse. (Investor's Business Daily)
07:45AM	Loading…
07:45AM	5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now (24/7 Wall St.)
07:08AM	White Houses online service for drug sales debuts with limited impact on prices (BioPharma Dive)
06:45AM	FDA Grants Priority Review for HYMPAVZI (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need (Business Wire)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
Feb-05-26 09:17PM	Trump launches TrumpRX website offering discounted prescription drugs (Investing.com)
08:06PM	Adaptive Biotechnologies Q4 Earnings Call Highlights (MarketBeat)
07:09PM	Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans (Business Wire)
05:22PM	Pfizer Pops on Q4 Results-But This May Be the Catalyst That Matters Most (MarketBeat)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
01:29PM	Bristol Myers Earnings Reveal Struggling Legacy Drug Business. Why the Stock Is Rising. (Barrons.com)
10:49AM	Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates (Zacks)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
08:21AM	The Week Ahead: Inflation Data Hits Amid Earnings Season (Schaeffer's Research)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
03:00AM	Big Pharma CEOs set sights on massive growth in years to come (Pharma Voice)
Feb-04-26 09:35PM	Pfizer Inc. (PFE): A Bull Case Theory (Insider Monkey)
01:11PM	Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss (Insider Monkey)
11:40AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
08:45AM	Novo Nordisk: Pfizer weight loss drug offers credible new competition (Proactive)
04:51AM	Earnings roundup: Amgen vs. FDA, Pfizers defense and Mercks $70B-in-sales plan (BioPharma Dive)
01:08AM	Pfizer Q4 Earnings Call Highlights (MarketBeat)
12:32AM	PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds (StockStory)
Feb-03-26 11:35PM	Will the Market Crash in 2026? Here's What History Says and What to Do About It (Motley Fool)
11:09PM	Asian shares gained and gold and silver climb higher after a retreat on Wall St (Associated Press Finance)
09:49PM	Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off (Motley Fool)
06:03PM	Stocks to Watch Tuesday Recap: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
04:36PM	These Stocks Are Todays Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More (Barrons.com)
04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
04:09PM	Pfizer Dives; Why Lilly's Zepbound Still Looks Like The Weight-Loss Heavyweight (Investor's Business Daily)
04:03PM	Pfizer Inc (PFE) Q4 2025 Earnings Call Highlights: Strategic Acquisitions and Revenue Guidance ... (GuruFocus.com)
03:14PM	Analyst Report: Pfizer Inc. (Morningstar Research)
03:05PM	Stocks to Watch Tuesday: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
02:57PM	These Are The Worst 25 Stocks to Own in February (Schaeffer's Research)
02:48PM	Obesity Drug Bets Get a Reality Checkbut Investors Shouldnt Panic (The Wall Street Journal)
02:24PM	Stock market today: Dow, Nasdaq, S&P 500 sink as tech falters amid flood of earnings (Yahoo Finance)
02:06PM	Pfizer is at 'the end of the beginning' in entry to GLP-1s: CEO (Yahoo Finance Video)
01:59PM	Pfizer sets sights on R&D strategy amid modest FY25 results (Pharmaceutical Technology)
12:33PM	Stock market today: Nasdaq, S&P 500 slide as investors digest flood of tech earnings, government shutdown (Yahoo Finance)
12:33PM	Stock market today: Dow, Nasdaq, S&P 500 fall as investors digest flood of tech earnings, government shutdown (Yahoo Finance)
12:22PM	Pfizer Releases Early Obesity Data Showing Up to 12.3% Weight Loss (GuruFocus.com)
11:40AM	Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways (CNBC TV)
11:36AM	Why Pfizer Stock Dropped Today (Motley Fool)
11:32AM	Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data (Zacks)
11:30AM	Why Is Pfizer Stock Sliding Today (GuruFocus.com)
11:04AM	2 Pharma Stocks React to Quarterly Results, Guidance (Schaeffer's Research)
11:00AM	Market Awaits JOLTS Jobs Report (Zacks)
10:48AM	Pfizer shares drop on quarterly loss (AFP)
10:40AM	Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook (CNBC TV)
10:35AM	Pfizer Projects Revenue Dip in 2026 as Patent Losses Weigh (GuruFocus.com)
10:32AM	Pfizer Stock Drops On Obesity-Drug Study Data (The Wall Street Journal)
10:26AM	Q4 Earnings, JOLTS & a Changing of the Disney Guard (Zacks)
09:59AM	Pfizer Targets Monthly Obesity Shot. Why Lilly Could Still Have The Weight-Loss Heavyweight. (Investor's Business Daily)
09:36AM	Stock market today: Nasdaq, S&P 500 fall as investors digest flood of tech earnings, partial government shutdown (Yahoo Finance)
09:36AM	Stock market today: Dow, S&P 500, Nasdaq edge higher as Palantir lifts tech hopes, earnings flood in (Yahoo Finance)
09:30AM	Pfizer (PFE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:02AM	S&P 500, Nasdaq poised for higher open as earnings deluge takes center stage (Reuters)
08:50AM	Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops (Benzinga)
08:19AM	Pharma stocks slump as Pfizer and Merck report earnings (Quartz)
08:19AM	Merck and Pfizer decline vs the broader market as results released (Quartz)
07:55AM	Pfizer (PFE) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:38AM	Pfizer Reaffirms FY26 Outlook As Q4 Results Top Estimates - Update (RTT News)
07:28AM	Pfizer says once-a-month weight-loss drug works as it forecasts profit decline (MarketWatch)
07:24AM	Jim Cramer Expresses Concern About Pfizer Despite Its "Terrific Yield" (Insider Monkey)
07:21AM	Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand (The Wall Street Journal)
07:19AM	Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025 (StockStory)
07:02AM	Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. (Barrons.com)
06:53AM	Pfizer: Q4 Earnings Snapshot (Associated Press Finance)
06:45AM	Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance (Business Wire)
06:40AM	Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial (Business Wire)
05:25AM	These Stocks Are Moving the Most Today: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, and More (Barrons.com)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM

Open in Screener

KMX

Carmax Inc

Feb 17 • 04:00PM ET

42.25

+0.82 1.98 %

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: IJR VTI VB VBR VXF IJS SPSM SLYV RWJ AVUV

Index	-	P/E	13.97	EPS (ttm)	3.02	Insider Own	0.55%	Shs Outstand	143.06M	Perf Week	-9.06%
Market Cap	5.99B	Forward P/E	16.98	EPS next Y	2.49	Insider Trans	1.67%	Shs Float	141.01M	Perf Month	-12.92%
Enterprise Value	23.26B	PEG	-	EPS next Q	0.18	Inst Own	100.36%	Short Float	10.17%	Perf Quarter	21.44%
Income	457.84M	P/S	0.22	EPS this Y	-17.28%	Inst Trans	-5.49%	Short Ratio	3.70	Perf Half Y	-26.85%
Sales	27.83B	P/B	1.00	EPS next Y	-6.30%	ROA	1.73%	Short Interest	14.34M	Perf YTD	9.34%
Book/sh	42.39	P/C	7.76	EPS next 5Y	-	ROE	7.46%	52W High	89.47 -52.78%	Perf Year	-52.47%
Cash/sh	5.45	P/FCF	3.07	EPS past 3/5Y	-22.80% -9.64%	ROIC	1.97%	52W Low	30.26 39.62%	Perf 3Y	-42.08%
Dividend Est.	-	EV/EBITDA	22.30	Sales past 3/5Y	-5.28% 5.66%	Gross Margin	11.31%	Volatility	6.47% 4.62%	Perf 5Y	-65.51%
Dividend TTM	-	EV/Sales	0.84	EPS Y/Y TTM	2.78%	Oper. Margin	2.50%	ATR (14)	2.15	Perf 10Y	-11.89%
Dividend Ex-Date	-	Quick Ratio	0.51	Sales Y/Y TTM	0.12%	Profit Margin	1.65%	RSI (14)	42.81	Recom	3.14
Dividend Gr. 3/5Y	- -	Current Ratio	1.99	EPS Q/Q	-47.21%	SMA20	-7.29%	Beta	1.35	Target Price	34.67
Payout	0.00%	Debt/Eq	2.98	Sales Q/Q	-6.73%	SMA50	-1.87%	Rel Volume	1.23	Prev Close	41.43
Employees	30048	LT Debt/Eq	2.84	Earnings	Dec 18 BMO	SMA200	-19.47%	Avg Volume	3.88M	Price	42.25
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.34% 2.71%	Trades		Volume	4,752,286	Change	1.98%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86
Mar-20-24	Upgrade	Needham	Hold → Buy	$99

Show Previous Ratings

Feb-14-26 02:26PM	Carvana Drops 15% This Week: Heres The 3 Biggest Storylines (24/7 Wall St.)
Feb-13-26 08:56AM	$1 Billion Accounting Questions Cloud Carvanas 44% Sales Surge (24/7 Wall St.)
Feb-12-26 07:36AM	CarMax Names a New CEO. He's Not a Car Guy. (Barrons.com) -10.57%
09:43AM	CarMax Taps Former Hotel CEO Keith Barr After Sales Slump (Transport Topics)
09:00AM	Wallace Weitz Exits CarMax Inc, Impacting Portfolio by -1.58% (GuruFocus.com)
09:00AM	Loading…
09:00AM	Eclipse backs all-EV marketplace Ever in $31M funding round (TechCrunch)
06:50AM	CarMax Names Keith Barr as Chief Executive Officer (Business Wire)
06:20AM	CarMax Taps Hotel Veteran to Lead Turnaround (The Wall Street Journal)
Feb-08-26 11:41PM	1 Safe-and-Steady Stock Worth Investigating and 2 We Question (StockStory)
Feb-04-26 07:30AM	CarMax Named One of TIME's America's Most Iconic Companies (GlobeNewswire)
05:44AM	CarMax, Inc. (KMX) Turns to Pricing and Marketing Actions to Revitalize Sales (Insider Monkey)
Feb-03-26 11:35PM	1 Profitable Stock to Target This Week and 2 We Turn Down (StockStory)
Jan-30-26 09:24AM	Giverny Capital Asset Management Exited Its Long-Term Holding CarMax (KMX) in 2025 (Insider Monkey)
Jan-23-26 08:56AM	Should You Hold CarMax (KMX)? (Insider Monkey)
Jan-14-26 07:50AM	CarGurus Pivots Beyond Marketplace at Needham Conference, Ramping AI and Dealer Software Push (MarketBeat)
11:05PM	Loading…
Jan-13-26 11:05PM	3 Reasons KMX is Risky and 1 Stock to Buy Instead (StockStory)
Jan-12-26 11:43AM	Why CarMax Stock Slipped 53% In 2025 (Motley Fool)
Jan-07-26 05:59AM	CarMax promises price relief for used-car customers (Wards Auto) +5.35%
Dec-31-25 09:51AM	Here's Why You Should Offload CarMax Stock From Your Portfolio (Zacks)
Dec-26-25 09:16AM	Can Carvana Stock Extend Its Strong 2025 Rally Into 2026? (Zacks)
Dec-25-25 12:31AM	The 5 Most Interesting Analyst Questions From CarMax's Q4 Earnings Call (StockStory)
Dec-22-25 08:59AM	Bear of the Day: CarMax (KMX) (Zacks)
03:34AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-20-25 10:00AM	3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500 (MarketBeat)
Dec-19-25 07:38AM	CarMax Q3 Earnings Surpass Expectations, Revenues Decline Y/Y (Zacks)
12:30AM	KMX Q4 Deep Dive: Margin Reset and Leadership Transition Dominate CarMax's Strategy (StockStory)
Dec-18-25 04:18PM	Stocks to Watch Thursday: Trump Media, Micron, Lululemon, Accenture (The Wall Street Journal)
04:01PM	CarMax Inc (KMX) Q3 2026 Earnings Call Highlights: Navigating Sales Decline and Strategic ... (GuruFocus.com)
12:57PM	CarMax Cutting Prices to Draw Car Shoppers Back (The Wall Street Journal)
12:36PM	CarMax Crashes into a Sales Slump as Amazon Circles the Used-Car Lot (GuruFocus.com)
11:53AM	Loading…
11:53AM	These Stocks Are Moving the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)
10:49AM	CarMax Scores an Earnings Beat. The Stock Barely Moves. (Barrons.com)
10:46AM	Stock Market Today: Indexes Rise; Nvidia, Tesla Rally But Some Electronics Firms Struggle (Live Coverage) (Investor's Business Daily)
10:15AM	Stock Market Today: Dow, Small Caps Rise On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:37AM	Stock Market Today: Dow Rises On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:30AM	CarMax (KMX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	CarMax (KMX) Q3 Earnings and Revenues Top Estimates (Zacks)
07:40AM	CarMax flags lower margins, higher marketing spend; shares slide (Investing.com)
07:18AM	CarMax Beats Earnings Expectations. Why the Stock Is Falling. (Barrons.com)
07:16AM	CarMax Profit Sinks as Struggles Continue (The Wall Street Journal)
07:13AM	CarMax (NYSE:KMX) Beats Q4 CY2025 Sales Expectations (StockStory)
07:00AM	CarMax: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports Third Quarter Fiscal Year 2026 Results (Business Wire)
05:33AM	Nike headlines Thursday's earnings slate (MarketWatch)
04:24AM	Stock Market Today: S&P 500 and Dow strive to break 4-day losing streak, Nasdaq called higher as Micron results lift tech sentiment; CPI inflation data due; Nike earnings on tap. (MarketWatch)
03:26AM	FedEx, Nike Earnings; Inflation Report: Still to Come This Week (The Wall Street Journal)
Dec-17-25 07:00PM	November CPI, Nike earnings, mortgage rates: What to Watch (Yahoo Finance Video)
Dec-16-25 10:34PM	Spotting Winners: CarMax (NYSE:KMX) And Vehicle Retailer Stocks In Q3 (StockStory)
10:01PM	CarMax Earnings: What To Look For From KMX (StockStory)
Dec-15-25 12:48PM	Reddit Investors Have No Faith in Used Car Stocks \| CVNA CARS CARG (24/7 Wall St.)
11:20AM	Tesla Owner Regrets Thinking His EV Was An 'Investment'Says He's 'Genuinely Shocked At How Much These Things Are Tanking' After Losing $750 A Month (Benzinga)
09:15AM	Stay Ahead of the Game With CarMax (KMX) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Dec-14-25 07:31AM	Trump's Fed pick comes into focus, economic data backlog clears: What to watch this week (Yahoo Finance)
05:00AM	What to Expect in Markets This Week: Jobs Report, Inflation Data, Earnings From Micron, Nike and FedEx (Investopedia)
Dec-11-25 12:29PM	Carvana Stock Is Joining the S&P 500. Should You Buy Shares Now? (Barchart)
10:00AM	Earnings Preview: CarMax (KMX) Q3 Earnings Expected to Decline (Zacks)
09:15AM	Vera Bradley (VRA) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
08:38AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
07:50AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-09-25 11:59AM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
09:00AM	CarMax, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - KMX (PR Newswire)
08:05AM	AutoZone (AZO) Q1 Earnings and Revenues Miss Estimates (Zacks)
Dec-08-25 02:39PM	Carvana Stock Heads for a New High. There's More to the Story Than S&P 500 Inclusion. (Barrons.com)
12:16PM	Carvana Stock Heads for Record Closing High. There's More to Story Than S&P 500 Inclusion. (Barrons.com)
11:30AM	Carvana stock surges on S&P 500 inclusion, marking dramatic turnaround (Yahoo Finance)
08:31AM	Here's What Affected CarMax (KMX) in Q3 (Insider Monkey)
03:15AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-05-25 08:56AM	Wedbush Says Its Time to Take Advantage and Buy the Dip in This 1 Former Meme Stock (Barchart)
Dec-04-25 08:00AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
Dec-03-25 02:56PM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
Dec-02-25 01:16PM	The Real Price of Passive: Its Not the Expense Ratio (etf.com)
Dec-01-25 03:18PM	KMX SHAREHOLDERS: CarMax, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by January 2 (Newsfile)
Nov-30-25 02:15AM	What Every CarMax Investor Should Know Before Buying (Motley Fool)
Nov-29-25 10:48AM	Has KMX Stock Been Good for Investors? (Motley Fool)
Nov-28-25 05:55PM	CarMax, Inc. (KMX) Investor Lawsuit Filed, Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline -- Hagens Berman (PR Newswire)
07:48AM	Is CarMax (KMX) Facing Cyclical Weakness? (Insider Monkey)
Nov-25-25 05:00PM	Carmax Announces Third Quarter Conference Call (Business Wire) +5.33%
08:45AM	Investors in CarMax, Inc. Should Contact Levi & Korsinsky Before January 2, 2026 to Discuss Your Rights - KMX (PR Newswire)
Nov-24-25 02:54PM	Carvana Stock Is Rising. Ignore the Struggling Car Market, Say Analysts. (Barrons.com)
01:27PM	Is Carvana the 'New Used Car King?' These Analysts Think So, and the Stock Is Rising. (Investopedia)
12:30PM	Wedbush Lifts Carvana With $400 Target And 30% Upside (GuruFocus.com)
12:06PM	Carvana Stock Jumps. Ignore the Struggling Car Market, Say Analysts. (Barrons.com)
11:14AM	The Auto Market Is in Rough Shape. Buy Carvana Stock Anyway, Analyst Says. (Barrons.com)
02:41AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Nov-21-25 05:50PM	CarMax and Lithia Stocks Trade Up, What You Need To Know (StockStory) +5.40%
Nov-20-25 10:35AM	CarMax Opens First Arkansas Store in Rogers, Expanding to 42 States Nationwide (GlobeNewswire)
Nov-18-25 02:15PM	Why CarMax (KMX) Stock Is Up Today (StockStory)
09:00AM	CarMax Rolls Out Nationwide At-Home Pickup- Sell Your Car Without Leaving Your Driveway (GlobeNewswire)
Nov-17-25 11:34PM	3 Profitable Stocks We Steer Clear Of (StockStory) -6.74%
04:34PM	Amazon, Ford Partner on Used Cars. 4 Stocks That Could Be Impacted. (Barrons.com)
09:41AM	Carvana and CarMax stock falls after Ford partners with Amazon (Investing.com)
09:37AM	Ford Taps Amazon to Let Shoppers Buy Its Used Cars Online (Bloomberg)
09:00AM	Paige Bueckers and Donovan Mitchell Take the Wheel in CarMax's "Wanna Drive?" Campaign (GlobeNewswire)
Nov-16-25 10:03AM	Poorly Run CarMax (KMX) "Misjudged" The Market, Says Jim Cramer (Insider Monkey)
12:12AM	Jim Cramer on CarMax: "I Would Not Own That Stock" (Insider Monkey)
Nov-13-25 08:43PM	Lightning Round: ServiceNow's fundamentals are very good, says Jim Cramer (CNBC TV)
Nov-12-25 12:12PM	Is Carvana (CVNA) Actually In Trouble? (24/7 Wall St.)
09:45AM	Carvana initiated, AT upgraded: Wall Street's top analyst calls (The Fly)
02:49AM	CarMax Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Nov-11-25 12:26PM	Why CarMax (KMX) Stock Is Trading Up Today (StockStory)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM
STEENROD MITCHELL D	Director	Apr 24 '25	Buy	65.49	1,300	85,137	33,577	Apr 25 04:08 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your FINVIZ experience